menu ☰
menu ˟

Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project

16 Apr 2019

Biomarkers such as cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI) have predictive value for progression to dementia in patients with mild cognitive impairment (MCI). The pre-dementia stage take...

Click here to view the full article which appeared in Alzheimer's Research & Therapy